atenolol has been researched along with Angor Pectoris in 229 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In hypertensive patients with prior MI, a verapamil-SR-based strategy was equivalent to a beta-blocker-based strategy for blood pressure control and prevention of cardiovascular events, with greater subjective feeling of well-being and a trend toward lower incidence of angina pectoris and stroke in the verapamil-SR-based group." | 9.13 | Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. ( Bacher, PH; Bangalore, S; Champion, A; Cohen, JD; Kowey, P; Mancia, G; Messerli, FH; Pepine, CJ; Sleight, P; Zhou, Q, 2008) |
| " These posthoc analyses from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study evaluated losartan- versus atenolol-based therapy on the primary composite end point of cardiovascular death, stroke, and myocardial infarction and other end points in 4963 women." | 9.13 | Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study. ( Dahlöf, B; Devereux, RB; Franco, V; Gerdts, E; Hille, DA; Kjeldsen, SE; Lyle, PA; Manhem, K; Okin, PM; Oparil, S; Os, I, 2008) |
| "The aim of the study was to estimate clinical and functional indices under stable course of coronary heart disease (CHD) against the background of therapy with coraxan and atenolol." | 9.13 | [Coraxan and atenolol: similarities and differences in correction of clinical and functional indices in therapy of patients with coronary heart disease]. ( Biriuchenko, MV; Kapelovich, VIu; Pozdniakova, NV; Tatarchenko, IP, 2008) |
| "We investigated whether ranolazine therapy improves exercise-induced angina pectoris and myocardial ischemia compared with placebo or with standard doses of atenolol in patients who had chronic angina and evaluated the effects on hemodynamics at rest and during exercise." | 9.11 | Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. ( Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA, 2005) |
| "48 patients with stable angina pectoris were investigated (double-blind, randomized, parallel grouped) comparing the hemodynamic, anti-ischemic, metabolic and neurohumoral effects of tedisamil 100 mg b." | 9.09 | [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol]. ( Beckmann, K; Miskovic, A; Mitrovic, V; Pitschner, H; Straub, M; Thormann, J, 1999) |
| "The study was undertaken to evaluate whether the effect of combined amlodipine and atenolol therapy on patients with stable angina pectoris and with ST-depression during exercise testing and 48-h ambulatory electrocardiographic monitoring is superior to that of either agent given alone." | 9.09 | Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. ( Ekdahl, S; Karlson, BW; Pehrsson, SK; Persson, S; Ringqvist, I; Ulvenstam, G, 2000) |
| "Antianginal efficacy of atenolol (A) and isosorbide dinitrate (ID) was compared in a long-term randomized, single-blind, crossover, placebo controlled trial in 71 patients with combined stable angina pectoris and chronic hypotension (Hpts) and in 38 normotensive patients with angina of effort (Npts)." | 9.09 | [The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris]. ( Borovkova, NV; Chernov, VI; Idrisova, EM; Karpov, RS; Stepacheva, TA, 2001) |
| "Although the combined administration of atenolol and nifedipine has been shown to be effective in the treatment of angina pectoris the optimum dosage level of the combination has not yet been established." | 9.08 | A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris. ( Jennings, K; Metcalfe, MJ, 1995) |
| " To evaluate the efficacy and safety of this formulation and to compare this with the beta-blocker atenolol, we conducted a double-blind, randomised, multi-centre study in 129 male patients with documented exercise induced angina pectoris." | 9.08 | Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN). ( Bernink, PJ; Claessens, RJ; de Vries, RJ; Dunselman, PH; Kingma, JH; Lok, DJ; Pasteuning, WH; van den Heuvel, AF, 1996) |
| "This double-blind, randomised multicentre study compares nifedipine gastrointestinal therapeutic system (GITS) with atenolol in 129 male patients, with exercise-induced angina pectoris." | 9.08 | Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN). ( de Vries, RJ; Dunselman, PH, 1997) |
| " Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation." | 9.07 | A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "To monitor the tolerance and long-term efficacy of a low-dose fixed combination of 50 mg atenolol and 20 mg nifedipine (slow release formulation) in patients with stable angina pectoris, 157 patients received treatment twice daily in a multi-centre, open-label fashion for periods up to 12 months following a four week run-in period on atenolol 50 mg twice daily." | 9.07 | Tolerance and long-term efficacy of a fixed combination of atenolol and nifedipine in the treatment of angina pectoris. Stuart Clinical Research Group. ( Oliver, IM; Russell, WA; Saul, PA, 1992) |
| "We examined the importance of a long plasma half-life (t1/2) on the antianginal effects of beta-blockade by comparing equivalent doses of once-daily atenolol 100 mg (t1/2 6-8 h) and betaxolol 20 mg (t1/2 20-22 h) in a double-blind placebo-controlled cross-over study of 20 patients with stable angina pectoris." | 9.07 | Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol. ( Dargie, HJ; Findlay, IN; McLenachan, JM; Wilson, JT, 1992) |
| " chronic obstructive bronchitis were treated with the beta1-selective beta-blockers atenolol (50 mg) and bisoprolol (5 mg) for 6 months in each case, following a randomized, double-blind crossover study design." | 9.06 | Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study. ( Bethge, H; Disselhoff, G; Dorow, P; Thalhofer, S; Wagner, G, 1990) |
| "The efficacy of bopindolol and atenolol in the treatment of patients with chronic stable angina pectoris have been compared in a double blind, randomized study." | 9.06 | Comparison of bopindolol and atenolol in chronic stable angina pectoris. ( Fitscha, P; Meisner, W; Tiso, B, 1990) |
| "The effects of theophylline (400 mg twice a day), atenolol (50 mg twice a day) and their combination on myocardial ischemia were studied in 9 patients with stable angina pectoris in a randomized, single-blind, triple crossover trial." | 9.06 | Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris. ( Crea, F; Davies, GJ; el-Tamimi, H; Galassi, AR; Kaski, JC; Maseri, A; Pupita, G, 1990) |
| "32 patients with stable angina and a positive symptom-limited exercise test (SLET) were investigated in a double-blind randomized trial in order to assess the therapeutic efficacy of bopindolol or atenolol on the incidence of angina pectoris and on angina pectoris threshold heart rate (ATHR)." | 9.06 | Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial. ( Hertzeanu, H; Kellermann, JJ; Loidl, AF; Shemesh, J, 1989) |
| "To assess the effects of bevantolol on stable angina pectoris of effort and its impact on metabolic risk factors, a comparison study of this beta 1-blocking agent and atenolol was undertaken in 40 subjects (mean age 51 years)." | 9.06 | Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris. ( Rauramaa, R; Salonen, JT; Salonen, R; Seppänen, K; Taskinen, E; Venäläinen, J, 1986) |
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 9.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| "Once-daily atenolol and celiprolol were compared in a placebo-controlled crossover study of 16 patients with stable angina pectoris." | 9.06 | Atenolol and celiprolol for stable angina pectoris. ( Dargie, HJ; Findlay, IN; Henderson, E; McLenachan, JM; Wilson, JT, 1988) |
| "The efficacy and safety of the new cardioselective beta-blocker bisoprolol 5 mg and 10 mg once daily in the treatment of angina pectoris was compared with atenolol 100 mg once daily." | 9.06 | A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris. ( Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW, 1987) |
| "The antianginal effects of nifedipine 20 mg three times a day and atenolol 100 mg once a day singly and in combination were investigated in 16 patients with angina pectoris." | 9.06 | Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. ( Dargie, HJ; Elliott, AT; Findlay, IN; Ford, M; Gillen, G; MacLeod, K, 1986) |
| "Atenolol and nifedipine have been shown to be effective single agents in angina pectoris, but reports suggest that additional benefits may be conferred by combining the 2 drugs." | 9.06 | Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report. ( Foale, RA; Sandberg, M, 1988) |
| "The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol." | 9.06 | Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol. ( Crake, T; Fox, KM; Mockus, L; Quyyumi, AA; Wright, C, 1987) |
| "Working capacity, left ventricular ejection fraction (EF), stroke volume and the phase of the left ventricular contraction were tested before and after 3 weeks of atenolol treatment in 14 patients with angina pectoris and coronary insufficiency diagnosed by thallium tomography." | 9.06 | The effect of atenolol on the left ventricular performance in patients with angina pectoris measured with isotope technique. ( Balldin, M; Boström, PA; Johansson, B; Lilja, B, 1988) |
| "The efficacy and effect on cardiac function of verapamil 120 mg three times a day and atenolol 100 mg once a day, singly and in combination, were evaluated in 15 patients with angina pectoris." | 9.06 | A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. ( Aitchison, T; Dargie, HJ; Elliott, AT; Findlay, IN; Gillen, G; MacLeod, K, 1987) |
| "The long-term efficacy of once-daily atenolol cardioselective beta-blockade therapy for chronic stable angina pectoris was studied in nine coronary disease patients." | 9.05 | Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris. ( Harrison, DC; Jackson, G; Kates, RE; Schwartz, JB, 1981) |
| "The physiology, pharmacokinetics and efficacy of atenolol, a cardioselective beta-adrenergic blocking agent, were evaluated in 10 patients with stable angina pectoris in a single-blind, dose-ranging study." | 9.05 | Atenolol: once-daily cardioselective beta blockade for angina pectoris. ( Harrison, DC; Jackson, G; Kates, RE; Schwartz, J; Winchester, M, 1980) |
| "We have studied the effects of four doses of atenolol in 11 patients with stable angina pectoris using a symptom-limited exercise test and angina diaries." | 9.05 | A comparison of once and twice daily atenolol for angina pectoris. ( Boyle, RM; Bray, CL; Croxson, RS; Cruickshank, JM; Naqvi, N, 1983) |
| "Pharmacokinetics and clinical effects of daily oral doses of 100 mg and 200 mg atenolol, respectively, were studied in patients with angina pectoris by means of a double-blind cross-over randomized study." | 9.05 | Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris. ( de Feyter, PJ; Majid, PA; van der Vijgh, WJ; van der Wall, EE; Wardeh, R, 1980) |
| "We have compared oxyfedrine 24 mg four times daily with atenolol 100 mg once daily in the relief of angina pectoris in a double-blind cross-over study; assessments were by diary cards and treadmill testing." | 9.05 | Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study. ( Bray, C; Fananapazir, L, 1985) |
| "Nineteen men, aged 41-64 years, with stable angina pectoris have completed a random double-blind study of atenolol, 50 mg b." | 9.04 | Atenolol in the treatment of angina pectoris. ( Dedichen, J; Erikssen, J; Osvik, K, 1977) |
| "Fourteen patients with angina pectoris completed a double blind trial of atenolol 25 mg, 50 mg, and 100 mg twice daily and propranolol 80 mg thrice daily." | 9.04 | Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. ( Harry, JD; Jackson, G; Jewitt, DE; Kitson, D; Robinson, C, 1978) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 9.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "18 patients with angina pectoris participated in a double blind trial with atenolol (100 mg and 200 mg once daily, or 100 mg twice daily) and propranolol (80 mg twice daily)." | 9.04 | [Atenolol in the treatment of angina pectoris]. ( Bachmann, M; Burckhardt, D; Kappenberger, L; Münch, U; Nager, F; Raeber, E; Schwytzer, F, 1979) |
| "Nifedipine, as most calcium-antagonist drugs, is widely used for the treatment of angina pectoris and primary hypertension." | 8.80 | [Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report]. ( Luca, S; Romeo, S, 1999) |
| "Nifedipine and atenolol are first choice drugs in the treatment of arterial hypertension and angina pectoris." | 8.78 | [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris]. ( Verdecchia, P, 1993) |
| "Celiprolol was found to be an effective antianginal agent compared with placebo." | 7.76 | Celiprolol in angina pectoris. ( Frishman, WH; Soberman, JE, 1988) |
| "The effects of oral atenolol on coronary hemodynamics and prostaglandin metabolism have been investigated in 8 chronic stable angina pectoris patients who underwent the supine bicycle ergometer." | 7.69 | The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients. ( Kurita, A; Mizuno, K; Nagayoshi, H; Nishioka, T; Satomura, K; Takase, B; Uehata, A, 1994) |
| "16 patients suffering from hypertension and angina pectoris (class II according to the NYHA) are treated with 100 mg atenolol once daily for three weeks." | 7.66 | [Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris]. ( Attisano, N; Grenci, G; Martelli, G; Sarica, G; Schirripa, V, 1982) |
| "Myocardial substrate extraction, coronary sinus flow, left ventricular pressure, and cardiac output were measured in 11 patients with angina pectoris at three pacing rates before and after atenolol (0." | 7.66 | Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. ( Coltart, DJ; Jenkins, BS; Juul, SM; Naqvi, N; Thompson, DS; Webb-Peploe, MM, 1980) |
| "Anginal patients who remain symptomatic despite optimally dosed beta blockade may also be given dihydropyridine calcium antagonists." | 6.69 | Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. ( Bernink, PJ; Bouwens, LH; Dunselman, PH; Herweijer, AH; Holwerda, KJ; van Kempen, LH, 1998) |
| "This multicenter, randomized, double-blind, parallel group, placebo lead-in, placebo-controlled study compared the antianginal and anti-ischemic effects of once-daily bedtime dosing of controlled-onset extended-release (COER-24) verapamil to a once-daily morning dosing of amlodipine +/- atenolol in patients with chronic stable angina." | 6.69 | Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. ( Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P, 1999) |
| "Atenolol is a pure beta 1-selective antagonist with more pronounced effects on blood pressure and heart rate at rest." | 6.67 | The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group. ( Boberg, J; Larsen, FF; Pehrsson, SK, 1992) |
| " There were no significant differences regarding nature and incidence of adverse events between the groups." | 6.67 | Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA). ( Buchner-Moell, D; de Muinck, ED; Lie, KI; van de Ven, LL, 1992) |
| "In atenolol-treated patients with severe effort angina pectoris, nifedipine 20 mg tid improved exercise capacity, while nisoldipine 20 mg once daily did not have a similar effect." | 6.67 | Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. ( Kantor, M; Pedersen, TR, 1990) |
| " However, 2 h after dosing there was a significant prolongation during stress testing in the time to onset of both 1 mm ST depression on the ECG (by 28%) and to angina (by 37%) compared with atenolol alone, but no benefit was apparent by 12 h after dosing." | 6.66 | Slow release nifedipine plus atenolol in chronic stable angina pectoris. ( Challenor, VF; George, CF; Renwick, AG; Waller, DG, 1989) |
| " Treatment was titrated to produce at least a 30% increase in treadmill exercise duration over placebo baseline and then maintained at that dosage for an additional 3 weeks." | 6.66 | Comparison of atenolol and nifedipine in chronic stable angina pectoris. ( Kostis, JB; Narahara, KA; Shapiro, W; Thandroyen, F; Zohman, LR, 1989) |
| "Bisoprolol is a new cardioselective beta-blocker with a long half-life." | 6.66 | Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up. ( Hughes, LO; Kardash, MM; Khurmi, NS; Kohli, RS; Lahiri, A; Raftery, EB, 1985) |
| "Labetalol and atenolol were equivalent in control of blood pressure at rest, exercise tolerance and use of nitroglycerin; however, heart rates at rest and during exercise were higher with labetalol (p less than 0." | 6.66 | Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris. ( Jee, LD; Opie, LH, 1985) |
| " The data suggest that in the treatment of angina on effort, beta blockers should be prescribed according to their pharmacokinetic properties to achieve adequate suppression of the heart rate during exercise." | 6.65 | Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics. ( Cosgrove, NM; Kostis, JB; Krieger, SD; Lacy, CR, 1984) |
| "Atenolol is a beta-selective (cardioselective) adrenoceptor blocking drug without partial agonist or membrane stabilising activity." | 6.36 | Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1979) |
| " In a double-blind study of ten patients with stable angina pectoris treated with nifedipine, propranolol, and atenolol, smoking was found to have direct and adverse effects on the heart and to interfere with the efficacy of all three antianginal drugs, but with that of nifedipine the most." | 6.16 | Smoking, catecholamines, and the ischemic myocardium. ( Fox, KM, 1988) |
| " and atenolol at the commonly used dosage in clinical practice in patients with chronic stable angina pectoris produced additional efficacy with no untoward effect on safety or tolerability." | 5.14 | Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. ( Kahan, T; Ponikowski, P; Tardif, JC, 2009) |
| "In hypertensive patients with prior MI, a verapamil-SR-based strategy was equivalent to a beta-blocker-based strategy for blood pressure control and prevention of cardiovascular events, with greater subjective feeling of well-being and a trend toward lower incidence of angina pectoris and stroke in the verapamil-SR-based group." | 5.13 | Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. ( Bacher, PH; Bangalore, S; Champion, A; Cohen, JD; Kowey, P; Mancia, G; Messerli, FH; Pepine, CJ; Sleight, P; Zhou, Q, 2008) |
| " These posthoc analyses from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study evaluated losartan- versus atenolol-based therapy on the primary composite end point of cardiovascular death, stroke, and myocardial infarction and other end points in 4963 women." | 5.13 | Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study. ( Dahlöf, B; Devereux, RB; Franco, V; Gerdts, E; Hille, DA; Kjeldsen, SE; Lyle, PA; Manhem, K; Okin, PM; Oparil, S; Os, I, 2008) |
| "The aim of the study was to estimate clinical and functional indices under stable course of coronary heart disease (CHD) against the background of therapy with coraxan and atenolol." | 5.13 | [Coraxan and atenolol: similarities and differences in correction of clinical and functional indices in therapy of patients with coronary heart disease]. ( Biriuchenko, MV; Kapelovich, VIu; Pozdniakova, NV; Tatarchenko, IP, 2008) |
| "To determine whether, at trough levels, ranolazine improves the total exercise time of patients who have symptoms of chronic angina and who experience angina and ischemia at low workloads despite taking standard doses of atenolol, amlodipine, or diltiazem and to determine times to angina onset and to electrocardiographic evidence of myocardial ischemia, effect on angina attacks and nitroglycerin use, and effect on long-term survival in an open-label observational study extension." | 5.11 | Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. ( Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA, 2004) |
| "We investigated whether ranolazine therapy improves exercise-induced angina pectoris and myocardial ischemia compared with placebo or with standard doses of atenolol in patients who had chronic angina and evaluated the effects on hemodynamics at rest and during exercise." | 5.11 | Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. ( Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA, 2005) |
| "48 patients with stable angina pectoris were investigated (double-blind, randomized, parallel grouped) comparing the hemodynamic, anti-ischemic, metabolic and neurohumoral effects of tedisamil 100 mg b." | 5.09 | [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol]. ( Beckmann, K; Miskovic, A; Mitrovic, V; Pitschner, H; Straub, M; Thormann, J, 1999) |
| "Four hundred seventy-five patients with angina pectoris were randomized to double-blind treatment with PPR (physiological pattern release) verapamil hydrochloride, amlodipine besylate, amlodipineatenolol combination, or placebo." | 5.09 | Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension. ( Anderson, R; Hollenberg, NK; Williams, GH, 2000) |
| "The study was undertaken to evaluate whether the effect of combined amlodipine and atenolol therapy on patients with stable angina pectoris and with ST-depression during exercise testing and 48-h ambulatory electrocardiographic monitoring is superior to that of either agent given alone." | 5.09 | Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. ( Ekdahl, S; Karlson, BW; Pehrsson, SK; Persson, S; Ringqvist, I; Ulvenstam, G, 2000) |
| "Antianginal efficacy of atenolol (A) and isosorbide dinitrate (ID) was compared in a long-term randomized, single-blind, crossover, placebo controlled trial in 71 patients with combined stable angina pectoris and chronic hypotension (Hpts) and in 38 normotensive patients with angina of effort (Npts)." | 5.09 | [The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris]. ( Borovkova, NV; Chernov, VI; Idrisova, EM; Karpov, RS; Stepacheva, TA, 2001) |
| "138 patients with chronic stable angina pectoris were randomized in a multicenter, double-blind trial to treatment with either mibefradil or atenolol for 6 weeks (50 mg once daily for 2 weeks followed by 100 mg once daily for 4 weeks)." | 5.09 | Different effects of calcium antagonist and beta-blocker therapy on left-ventricular diastolic function in ischemic heart disease. A direct comparison of the impact of mibefradil and atenolol. ( Fischer Hansen, J; Grande, P; Gustafsson, I; Hassager, C; Mickley, H; Skagen, K; Steensgaard-Hansen, F; Thygesen, K, 2001) |
| "Although the combined administration of atenolol and nifedipine has been shown to be effective in the treatment of angina pectoris the optimum dosage level of the combination has not yet been established." | 5.08 | A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris. ( Jennings, K; Metcalfe, MJ, 1995) |
| "This study was conducted to determine whether rebound ischemia occurs during nitrate-free periods with intermittent cutaneous nitroglycerin therapy in patients with angina pectoris who are receiving background antianginal therapy." | 5.08 | Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. ( Daxini, BV; Freedman, SB; Kelly, DT; Noyce, D, 1995) |
| " To evaluate the efficacy and safety of this formulation and to compare this with the beta-blocker atenolol, we conducted a double-blind, randomised, multi-centre study in 129 male patients with documented exercise induced angina pectoris." | 5.08 | Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN). ( Bernink, PJ; Claessens, RJ; de Vries, RJ; Dunselman, PH; Kingma, JH; Lok, DJ; Pasteuning, WH; van den Heuvel, AF, 1996) |
| "This double-blind, randomised multicentre study compares nifedipine gastrointestinal therapeutic system (GITS) with atenolol in 129 male patients, with exercise-induced angina pectoris." | 5.08 | Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN). ( de Vries, RJ; Dunselman, PH, 1997) |
| " Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation." | 5.07 | A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "This randomized, double-blind, parallel study compared the anti-anginal effects of nicorandil and atenolol in 37 patients with exercise-induced angina pectoris." | 5.07 | A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina. ( Hughes, LO; Lahiri, A; Raftery, EB; Rose, EL, 1993) |
| "The effects of the addition of slow-release nifedipine 20 mg twice daily and nisoldipine 10 mg twice daily to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with chronic stable angina pectoris." | 5.07 | A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "To monitor the tolerance and long-term efficacy of a low-dose fixed combination of 50 mg atenolol and 20 mg nifedipine (slow release formulation) in patients with stable angina pectoris, 157 patients received treatment twice daily in a multi-centre, open-label fashion for periods up to 12 months following a four week run-in period on atenolol 50 mg twice daily." | 5.07 | Tolerance and long-term efficacy of a fixed combination of atenolol and nifedipine in the treatment of angina pectoris. Stuart Clinical Research Group. ( Oliver, IM; Russell, WA; Saul, PA, 1992) |
| "We examined the importance of a long plasma half-life (t1/2) on the antianginal effects of beta-blockade by comparing equivalent doses of once-daily atenolol 100 mg (t1/2 6-8 h) and betaxolol 20 mg (t1/2 20-22 h) in a double-blind placebo-controlled cross-over study of 20 patients with stable angina pectoris." | 5.07 | Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol. ( Dargie, HJ; Findlay, IN; McLenachan, JM; Wilson, JT, 1992) |
| " chronic obstructive bronchitis were treated with the beta1-selective beta-blockers atenolol (50 mg) and bisoprolol (5 mg) for 6 months in each case, following a randomized, double-blind crossover study design." | 5.06 | Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study. ( Bethge, H; Disselhoff, G; Dorow, P; Thalhofer, S; Wagner, G, 1990) |
| "The efficacy of bopindolol and atenolol in the treatment of patients with chronic stable angina pectoris have been compared in a double blind, randomized study." | 5.06 | Comparison of bopindolol and atenolol in chronic stable angina pectoris. ( Fitscha, P; Meisner, W; Tiso, B, 1990) |
| "The effects of theophylline (400 mg twice a day), atenolol (50 mg twice a day) and their combination on myocardial ischemia were studied in 9 patients with stable angina pectoris in a randomized, single-blind, triple crossover trial." | 5.06 | Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris. ( Crea, F; Davies, GJ; el-Tamimi, H; Galassi, AR; Kaski, JC; Maseri, A; Pupita, G, 1990) |
| "The effects of once-daily dosing with celiprolol 200 mg, celiprolol 400 mg, and atenolol 100 mg have been studied in 19 male patients with chronic stable angina pectoris." | 5.06 | A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol. ( Jackson, NC; Lee, PS; Taylor, SH, 1986) |
| "32 patients with stable angina and a positive symptom-limited exercise test (SLET) were investigated in a double-blind randomized trial in order to assess the therapeutic efficacy of bopindolol or atenolol on the incidence of angina pectoris and on angina pectoris threshold heart rate (ATHR)." | 5.06 | Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial. ( Hertzeanu, H; Kellermann, JJ; Loidl, AF; Shemesh, J, 1989) |
| "To assess the effects of bevantolol on stable angina pectoris of effort and its impact on metabolic risk factors, a comparison study of this beta 1-blocking agent and atenolol was undertaken in 40 subjects (mean age 51 years)." | 5.06 | Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris. ( Rauramaa, R; Salonen, JT; Salonen, R; Seppänen, K; Taskinen, E; Venäläinen, J, 1986) |
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 5.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| "Once-daily atenolol and celiprolol were compared in a placebo-controlled crossover study of 16 patients with stable angina pectoris." | 5.06 | Atenolol and celiprolol for stable angina pectoris. ( Dargie, HJ; Findlay, IN; Henderson, E; McLenachan, JM; Wilson, JT, 1988) |
| "Celiprolol (400 mg) and atenolol (100 mg) were given once a day to 16 patients with stable angina pectoris in a double blind placebo controlled crossover study." | 5.06 | Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol. ( Dargie, HJ; McLenachan, JM; Wilson, JT, 1988) |
| "The efficacy and safety of the new cardioselective beta-blocker bisoprolol 5 mg and 10 mg once daily in the treatment of angina pectoris was compared with atenolol 100 mg once daily." | 5.06 | A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris. ( Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW, 1987) |
| "The antianginal effects of nifedipine 20 mg three times a day and atenolol 100 mg once a day singly and in combination were investigated in 16 patients with angina pectoris." | 5.06 | Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. ( Dargie, HJ; Elliott, AT; Findlay, IN; Ford, M; Gillen, G; MacLeod, K, 1986) |
| "Atenolol and nifedipine have been shown to be effective single agents in angina pectoris, but reports suggest that additional benefits may be conferred by combining the 2 drugs." | 5.06 | Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report. ( Foale, RA; Sandberg, M, 1988) |
| "The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol." | 5.06 | Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol. ( Crake, T; Fox, KM; Mockus, L; Quyyumi, AA; Wright, C, 1987) |
| "Working capacity, left ventricular ejection fraction (EF), stroke volume and the phase of the left ventricular contraction were tested before and after 3 weeks of atenolol treatment in 14 patients with angina pectoris and coronary insufficiency diagnosed by thallium tomography." | 5.06 | The effect of atenolol on the left ventricular performance in patients with angina pectoris measured with isotope technique. ( Balldin, M; Boström, PA; Johansson, B; Lilja, B, 1988) |
| "The efficacy and effect on cardiac function of verapamil 120 mg three times a day and atenolol 100 mg once a day, singly and in combination, were evaluated in 15 patients with angina pectoris." | 5.06 | A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. ( Aitchison, T; Dargie, HJ; Elliott, AT; Findlay, IN; Gillen, G; MacLeod, K, 1987) |
| "The long-term efficacy of once-daily atenolol cardioselective beta-blockade therapy for chronic stable angina pectoris was studied in nine coronary disease patients." | 5.05 | Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris. ( Harrison, DC; Jackson, G; Kates, RE; Schwartz, JB, 1981) |
| "The physiology, pharmacokinetics and efficacy of atenolol, a cardioselective beta-adrenergic blocking agent, were evaluated in 10 patients with stable angina pectoris in a single-blind, dose-ranging study." | 5.05 | Atenolol: once-daily cardioselective beta blockade for angina pectoris. ( Harrison, DC; Jackson, G; Kates, RE; Schwartz, J; Winchester, M, 1980) |
| "We have studied the effects of four doses of atenolol in 11 patients with stable angina pectoris using a symptom-limited exercise test and angina diaries." | 5.05 | A comparison of once and twice daily atenolol for angina pectoris. ( Boyle, RM; Bray, CL; Croxson, RS; Cruickshank, JM; Naqvi, N, 1983) |
| "The action of nifedipine given first intravenously and then orally was studied in nine patients undergoing investigation for angina pectoris who were already receiving atenolol (100-200 mg/daily) and who had been shown to be fully beta blocked (reduction in maximal heart rate by greater than 25%)." | 5.05 | Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. ( Krikler, DM; Razis, P; Rowland, E; Sugrue, D, 1983) |
| "The effect of nifedipine 20 mg three times daily and atenolol 100 mg once daily, singly and in combination on left ventricular ejection fraction, was investigated in 14 patients with chronic effort related angina pectoris." | 5.05 | The effects of nifedipine, atenolol and that combination on left ventricular function. ( Dargie, HJ; Findlay, IN, 1983) |
| "We administered atenolol to 10 patients with effort limiting angina pectoris." | 5.05 | Improved exercise performance following single daily dose of atenolol in stable angina. ( Balu, V; Dean, DC; Naughton, J; Zaki Masud, AR, 1983) |
| "Pharmacokinetics and clinical effects of daily oral doses of 100 mg and 200 mg atenolol, respectively, were studied in patients with angina pectoris by means of a double-blind cross-over randomized study." | 5.05 | Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris. ( de Feyter, PJ; Majid, PA; van der Vijgh, WJ; van der Wall, EE; Wardeh, R, 1980) |
| "In order to assess the therapeutical efficacy of atenolol in stable angina pectoris of effort, we studied 40 patients with a positive exercise stress test." | 5.05 | [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)]. ( Battaglia, R; Gruppillo, P; Maistrello, I; Masoni, A; Masoni, C, 1981) |
| "We have compared oxyfedrine 24 mg four times daily with atenolol 100 mg once daily in the relief of angina pectoris in a double-blind cross-over study; assessments were by diary cards and treadmill testing." | 5.05 | Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study. ( Bray, C; Fananapazir, L, 1985) |
| "Nineteen men, aged 41-64 years, with stable angina pectoris have completed a random double-blind study of atenolol, 50 mg b." | 5.04 | Atenolol in the treatment of angina pectoris. ( Dedichen, J; Erikssen, J; Osvik, K, 1977) |
| "Fourteen patients with angina pectoris completed a double blind trial of atenolol 25 mg, 50 mg, and 100 mg twice daily and propranolol 80 mg thrice daily." | 5.04 | Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. ( Harry, JD; Jackson, G; Jewitt, DE; Kitson, D; Robinson, C, 1978) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 5.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "18 patients with angina pectoris participated in a double blind trial with atenolol (100 mg and 200 mg once daily, or 100 mg twice daily) and propranolol (80 mg twice daily)." | 5.04 | [Atenolol in the treatment of angina pectoris]. ( Bachmann, M; Burckhardt, D; Kappenberger, L; Münch, U; Nager, F; Raeber, E; Schwytzer, F, 1979) |
| " We also now have another bradycardic agent, ivabradine, which may prove very useful in heart failure patients who cannot tolerate a betablocker." | 4.84 | [What are the alternatives to betablockers in 2009?]. ( van de Borne, P, 2008) |
| "A short cut review was carried out to establish whether a glucagon infusion is of benefit in patients with refractory anaphylaxis." | 4.82 | Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. ( Crawford, I; Thomas, M, 2005) |
| "Nifedipine, as most calcium-antagonist drugs, is widely used for the treatment of angina pectoris and primary hypertension." | 4.80 | [Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report]. ( Luca, S; Romeo, S, 1999) |
| "Nifedipine and atenolol are first choice drugs in the treatment of arterial hypertension and angina pectoris." | 4.78 | [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris]. ( Verdecchia, P, 1993) |
| "In 9193 hypertensive patients included in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study, we measured urine albumin/creatinine ratio (UACR), LV hypertrophy by electrocardiography, serum high-density lipoprotein (HDL) cholesterol, and blood pressure after 2 weeks of placebo treatment and yearly during 5 years of anti-hypertensive treatment with either an atenolol- or a losartan-based regimen." | 3.76 | Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study. ( Dahlöf, B; Devereux, RB; Kjeldsen, SE; Okin, PM; Olsen, MH; Søraas, CL; Tønnessen, T; Wachtell, K, 2010) |
| "Celiprolol was found to be an effective antianginal agent compared with placebo." | 3.76 | Celiprolol in angina pectoris. ( Frishman, WH; Soberman, JE, 1988) |
| "Celiprolol hydrochloride is a highly cardioselective beta1-adrenergic antagonist with a unique pharmacologic profile." | 3.76 | Safety profile of celiprolol. ( Lamon, KD, 1988) |
| "To study a relationship between reduced heart rate variability and ventricular ectopic activity in patients with coronary artery disease and also efficiency of atenolol in suppression of ventricular arrhythmias and increase of heart rate variability." | 3.70 | [Depression of diurnal dispersion of sinus rhythm in patients after myocardial infarct]. ( Kaliuzhin, VV; Maleeva, MA; Pushnikova, EIu; Solovtsov, MA; Tepliakov, AT, 2000) |
| "The effects of oral atenolol on coronary hemodynamics and prostaglandin metabolism have been investigated in 8 chronic stable angina pectoris patients who underwent the supine bicycle ergometer." | 3.69 | The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients. ( Kurita, A; Mizuno, K; Nagayoshi, H; Nishioka, T; Satomura, K; Takase, B; Uehata, A, 1994) |
| "The effects of abrupt withdrawal of atenolol, a long acting cardioselective beta blocker, were studied in 20 patients with severe stable angina pectoris admitted to hospital for coronary arteriography." | 3.67 | Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment. ( Barritt, DW; Bauminger, B; Farr, S; Marshall, AJ; Walker, PR; Walters, G, 1985) |
| "The calcium-channel blocker, nifedipine, was used as additional oral therapy to beta-adrenergic receptor blockade by the cardioselective agent, atenolol, in the therapy of 31 patients with hypertension." | 3.66 | Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. ( Jee, L; Opie, LH; White, D, 1982) |
| "16 patients suffering from hypertension and angina pectoris (class II according to the NYHA) are treated with 100 mg atenolol once daily for three weeks." | 3.66 | [Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris]. ( Attisano, N; Grenci, G; Martelli, G; Sarica, G; Schirripa, V, 1982) |
| "Myocardial substrate extraction, coronary sinus flow, left ventricular pressure, and cardiac output were measured in 11 patients with angina pectoris at three pacing rates before and after atenolol (0." | 3.66 | Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. ( Coltart, DJ; Jenkins, BS; Juul, SM; Naqvi, N; Thompson, DS; Webb-Peploe, MM, 1980) |
| "Aim of this study was to assess clinical and pharmacoeconomic effects of long term use of adrenoblockers in patients with ischemic heart disease (IHD) undergoing coronary artery bypass grafting." | 2.75 | [Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting]. ( Dronova, EP; Lopatin, IuM, 2010) |
| "Ivabradine has shown anti-ischaemic and anti-anginal activity in a placebo-controlled trial." | 2.71 | Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. ( Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M, 2005) |
| "Treatment with atenolol was associated with symptomatic improvement and increase of the total exercise time." | 2.70 | [Atenolol induced bradycardia in patients with stable angina: effects on exercise tolerance, myocardial perfusion and left ventricular contractility]. ( Safonova, EV; Samoĭlenko, LE; Sergienko, VB; Zharova, EA, 2002) |
| "Anginal patients who remain symptomatic despite optimally dosed beta blockade may also be given dihydropyridine calcium antagonists." | 2.69 | Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. ( Bernink, PJ; Bouwens, LH; Dunselman, PH; Herweijer, AH; Holwerda, KJ; van Kempen, LH, 1998) |
| "This multicenter, randomized, double-blind, parallel group, placebo lead-in, placebo-controlled study compared the antianginal and anti-ischemic effects of once-daily bedtime dosing of controlled-onset extended-release (COER-24) verapamil to a once-daily morning dosing of amlodipine +/- atenolol in patients with chronic stable angina." | 2.69 | Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. ( Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P, 1999) |
| "Nifedipine gastrointestinal therapeutic system (GITS) is a once-daily formulation of nifedipine that provides stable plasma concentrations over the entire 24 h dosing interval." | 2.69 | Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina. ( Baird, MG; Bélanger, L; Erne, P; Klinke, P; Kostuk, WJ; Lotan, C; Marmor, A; Motro, M; Palant, A; Sclarowski, S; Stolero, D; Toal, CB; Turpie, A; Weiss, A; Zilberman, A, 1999) |
| "Tedisamil is a new bradycardic agent proven to exert antiischemic and antiarrhythmic effects by blockade of the cellular cardiac repolarization K+ currents as well as of multiple neuronal and vascular K+ currents (Ito, Ik, and K+ATP)." | 2.69 | Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists. ( Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J, 2000) |
| "Celiprolol is a novel beta 1 selective adrenoreceptor blocker with partial beta 2 agonism and direct vasodilator activity." | 2.67 | Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol. ( Christie, J; Dargie, HJ; Ford, I; Grant, S; Henderson, E; MacFarlane, N; McCann, G; Norrie, J; Ray, SG, 1994) |
| " After a 4 week run-in period on atenolol, patients were randomly allocated to receive either atenolol alone or its combination with nifedipine and then crossed over to the alternative treatment for a further 4 weeks." | 2.67 | Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. ( Adnams, C; Commerford, P; Meyer, TE, 1993) |
| "Amlodipine is a recently introduced, dihydropyridine with a long half life." | 2.67 | Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial. ( Channer, KS; Morice, AH; Stewart, AG; Woodmansey, PA, 1993) |
| "Atenolol is a pure beta 1-selective antagonist with more pronounced effects on blood pressure and heart rate at rest." | 2.67 | The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group. ( Boberg, J; Larsen, FF; Pehrsson, SK, 1992) |
| " There were no significant differences regarding nature and incidence of adverse events between the groups." | 2.67 | Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA). ( Buchner-Moell, D; de Muinck, ED; Lie, KI; van de Ven, LL, 1992) |
| "Nitroglycerin patches were superior to the placebo throughout the day, but in a declining degree--by 94 s at 19." | 2.67 | A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration. ( Bassan, MM; Rogel, S, 1992) |
| "In atenolol-treated patients with severe effort angina pectoris, nifedipine 20 mg tid improved exercise capacity, while nisoldipine 20 mg once daily did not have a similar effect." | 2.67 | Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. ( Kantor, M; Pedersen, TR, 1990) |
| " However, 2 h after dosing there was a significant prolongation during stress testing in the time to onset of both 1 mm ST depression on the ECG (by 28%) and to angina (by 37%) compared with atenolol alone, but no benefit was apparent by 12 h after dosing." | 2.66 | Slow release nifedipine plus atenolol in chronic stable angina pectoris. ( Challenor, VF; George, CF; Renwick, AG; Waller, DG, 1989) |
| " It improved the side effect profile in some but not all patients." | 2.66 | Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina. ( Adam, G; Akhras, F; Chambers, J; Jackson, G; Ong, ML, 1989) |
| " Treatment was titrated to produce at least a 30% increase in treadmill exercise duration over placebo baseline and then maintained at that dosage for an additional 3 weeks." | 2.66 | Comparison of atenolol and nifedipine in chronic stable angina pectoris. ( Kostis, JB; Narahara, KA; Shapiro, W; Thandroyen, F; Zohman, LR, 1989) |
| "Bisoprolol is a new cardioselective beta-blocker with a long half-life." | 2.66 | Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up. ( Hughes, LO; Kardash, MM; Khurmi, NS; Kohli, RS; Lahiri, A; Raftery, EB, 1985) |
| "Nifedipine was not better than placebo." | 2.66 | Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection? ( Caiazzo, MR; Carella, G; Chiariello, M; Condorelli, M; Cotecchia, MR; de Arcangelis, E; Di Maro, T; Romano, M, 1988) |
| "Diltiazem was compared to atenolol in a double-blind trial involving 78 patients suffering from coronary heart disease." | 2.66 | A comparison of diltiazem and atenolol in angina. ( Wheatley, D, 1985) |
| "Labetalol and atenolol were equivalent in control of blood pressure at rest, exercise tolerance and use of nitroglycerin; however, heart rates at rest and during exercise were higher with labetalol (p less than 0." | 2.66 | Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris. ( Jee, LD; Opie, LH, 1985) |
| " The data suggest that in the treatment of angina on effort, beta blockers should be prescribed according to their pharmacokinetic properties to achieve adequate suppression of the heart rate during exercise." | 2.65 | Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics. ( Cosgrove, NM; Kostis, JB; Krieger, SD; Lacy, CR, 1984) |
| "Nitroglycerine consumption was less on A-50 (p less than 0." | 2.65 | Atenolol once daily in angina. ( Karhumäki, L; Mäkynen, P; Seppänen, S, 1979) |
| "Allergic reactions, including anaphylactoid shock due to contrast material, are not uncommon." | 2.39 | Refractory anaphylactoid shock potentiated by beta-blockers. ( Javeed, H; Javeed, N; Javeed, S; Moussa, G; Rezai, F; Wong, P, 1996) |
| "Atenolol is a beta-selective (cardioselective) adrenoceptor blocking drug without partial agonist or membrane stabilising activity." | 2.36 | Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1979) |
| "In support of clinical antianginal studies, the vasodilator nicorandil (NIC) was combined with the beta-adrenergic receptor antagonists propranolol (PRO) and atenolol (ATN) and with the calcium channel blocker diltiazem (DTZ) to determine their cardiovascular and pharmacokinetic interactions." | 1.30 | Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs. ( Humphrey, SJ, 1998) |
| "Atenolol and nadolol have been ascertained to be effective long acting antianginal drugs." | 1.27 | [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina]. ( Desiatnichenko, VM; Romakov, AIu; Sagirov, AM; Sobol', IuS; Sumarokov, AB, 1983) |
| " However, as dosage adjustment and close observation may be necessary to minimise side effects, the use of this combination should be limited to hospital practice." | 1.27 | Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy. ( McGourty, JC; Silas, JH; Solomon, SA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 114 (49.78) | 18.7374 |
| 1990's | 78 (34.06) | 18.2507 |
| 2000's | 31 (13.54) | 29.6817 |
| 2010's | 6 (2.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jani, SM | 1 |
| Nallamothu, BK | 1 |
| Cooper, LT | 1 |
| Smith, A | 1 |
| Fazel, R | 1 |
| Tatarchenko, IP | 2 |
| Pozdniakova, NV | 2 |
| Biriuchenko, MV | 2 |
| Bangalore, S | 1 |
| Messerli, FH | 1 |
| Cohen, JD | 1 |
| Bacher, PH | 1 |
| Sleight, P | 1 |
| Mancia, G | 1 |
| Kowey, P | 1 |
| Zhou, Q | 1 |
| Champion, A | 1 |
| Pepine, CJ | 5 |
| van de Borne, P | 1 |
| Tardif, JC | 2 |
| Ponikowski, P | 1 |
| Kahan, T | 1 |
| Sajadieh, A | 1 |
| Pasquale, F | 1 |
| Tomé-Esteban, MT | 1 |
| Morgagni, R | 1 |
| Elliott, P | 1 |
| de Silva, R | 1 |
| Fox, KM | 9 |
| Søraas, CL | 1 |
| Wachtell, K | 1 |
| Okin, PM | 2 |
| Dahlöf, B | 2 |
| Devereux, RB | 2 |
| Tønnessen, T | 1 |
| Kjeldsen, SE | 2 |
| Olsen, MH | 1 |
| Lopatin, IuM | 1 |
| Dronova, EP | 1 |
| Massé, JF | 1 |
| Safonova, EV | 1 |
| Zharova, EA | 1 |
| Samoĭlenko, LE | 1 |
| Sergienko, VB | 1 |
| Bossi, M | 2 |
| Tiberti, G | 2 |
| Oganov, RG | 1 |
| Lepakhin, VK | 1 |
| Fitilev, SB | 1 |
| Levin, AM | 1 |
| Titarova, YY | 1 |
| Sytchev, EN | 1 |
| Donaldson, KM | 2 |
| Dawkins, KD | 2 |
| Waller, DG | 4 |
| Tepliakov, AT | 2 |
| Gavrilova, NV | 1 |
| Garganeeva, AA | 1 |
| Chaitman, BR | 2 |
| Parker, JO | 1 |
| Skopal, J | 1 |
| Chumakova, G | 1 |
| Kuch, J | 1 |
| Wang, W | 1 |
| Skettino, SL | 1 |
| Wolff, AA | 2 |
| Comella, A | 1 |
| Magnacca, M | 1 |
| Gistri, R | 1 |
| Lombardi, M | 1 |
| Neglia, D | 1 |
| Poddighe, R | 1 |
| Pesola, A | 1 |
| Gratsianskiĭ, NA | 1 |
| Rousseau, MF | 1 |
| Pouleur, H | 1 |
| Cocco, G | 1 |
| Thomas, M | 1 |
| Crawford, I | 1 |
| Medkova, IL | 1 |
| Ieromuzo, AA | 1 |
| Ivanov, AN | 1 |
| Mosiakina, LI | 1 |
| Biriukova, LS | 1 |
| Ford, I | 4 |
| Tendera, M | 1 |
| Bourassa, MG | 2 |
| Fox, K | 3 |
| Os, I | 1 |
| Franco, V | 1 |
| Manhem, K | 1 |
| Gerdts, E | 1 |
| Hille, DA | 1 |
| Lyle, PA | 1 |
| Oparil, S | 1 |
| Kapelovich, VIu | 1 |
| Schwartz, JB | 1 |
| Jackson, G | 7 |
| Kates, RE | 2 |
| Harrison, DC | 2 |
| Koch-Weser, J | 1 |
| Frishman, WH | 5 |
| Opie, LH | 3 |
| Jee, L | 1 |
| White, D | 1 |
| Segal, BL | 1 |
| Kotler, MN | 1 |
| Iskandrian, AS | 1 |
| Sánchez Cascos, A | 2 |
| Espín, A | 1 |
| Ramírez, M | 1 |
| De Rábago, P | 1 |
| Romakov, AIu | 1 |
| Sagirov, AM | 1 |
| Desiatnichenko, VM | 2 |
| Sobol', IuS | 1 |
| Sumarokov, AB | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Johns, VJ | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Kostis, JB | 4 |
| Lacy, CR | 1 |
| Krieger, SD | 1 |
| Cosgrove, NM | 1 |
| Quyyumi, AA | 3 |
| Wright, C | 4 |
| Mockus, L | 2 |
| Schwartz, J | 1 |
| Winchester, M | 1 |
| Boyle, RM | 1 |
| Bray, CL | 1 |
| Naqvi, N | 2 |
| Croxson, RS | 2 |
| Cruickshank, JM | 3 |
| Rowland, E | 1 |
| Razis, P | 1 |
| Sugrue, D | 1 |
| Krikler, DM | 1 |
| Deanfield, J | 1 |
| Krikler, S | 1 |
| Ribeiro, P | 1 |
| Findlay, IN | 5 |
| Dargie, HJ | 10 |
| Lessem, J | 1 |
| McGourty, JC | 2 |
| Silas, JH | 2 |
| Gimeno, JV | 1 |
| Olagüe, J | 1 |
| Bueno, FJ | 1 |
| Tellols, R | 1 |
| Martín, G | 1 |
| Ferrer, J | 1 |
| Oppenheim, G | 1 |
| Khadzhipetrov, N | 1 |
| Georgiev, S | 1 |
| Ellingsen, O | 1 |
| Kjekshus, J | 1 |
| Radice, M | 1 |
| Antongiovanni, GB | 1 |
| Corbetta, G | 1 |
| Folli, G | 1 |
| Bischoff, K | 1 |
| Hausen, T | 1 |
| Broustet, JP | 3 |
| Rumeau, P | 1 |
| Guern, P | 1 |
| Cherrier, JF | 1 |
| Pic, A | 1 |
| Bonnet, J | 1 |
| Mellini, M | 1 |
| Robutti, A | 1 |
| Mattiauda, C | 1 |
| Cavazzana, G | 1 |
| Roych, C | 1 |
| Sanfelici, D | 1 |
| Baccino, M | 1 |
| Reforzo, F | 1 |
| Balu, V | 1 |
| Zaki Masud, AR | 1 |
| Dean, DC | 1 |
| Naughton, J | 1 |
| Haghfelt, T | 1 |
| Pindborg, T | 1 |
| Thayssen, P | 1 |
| van der Vijgh, WJ | 2 |
| Majid, PA | 2 |
| de Feyter, PJ | 1 |
| Wardeh, R | 2 |
| van der Wall, EE | 2 |
| Gruppillo, P | 1 |
| Battaglia, R | 1 |
| Masoni, C | 1 |
| Maistrello, I | 1 |
| Masoni, A | 1 |
| de Divitiis, O | 1 |
| de Simone, G | 1 |
| Maddalena, G | 3 |
| Castaldo, M | 1 |
| Ruggiano, A | 1 |
| McNeil, GN | 1 |
| Shaw, PK | 1 |
| Dock, DS | 1 |
| Schirripa, V | 1 |
| Attisano, N | 1 |
| Sarica, G | 1 |
| Grenci, G | 1 |
| Martelli, G | 1 |
| Chlup, J | 1 |
| Engel, HJ | 1 |
| Pretschner, P | 1 |
| Lichtlen, PR | 1 |
| Harry, JD | 2 |
| Young, J | 1 |
| Barker, N | 1 |
| Thompson, DS | 1 |
| Juul, SM | 1 |
| Coltart, DJ | 1 |
| Jenkins, BS | 1 |
| Webb-Peploe, MM | 1 |
| White, DA | 1 |
| Arnold, IR | 1 |
| Mistry, R | 1 |
| Barnett, DB | 1 |
| Metcalfe, MJ | 1 |
| Jennings, K | 1 |
| Freedman, SB | 3 |
| Daxini, BV | 1 |
| Noyce, D | 1 |
| Kelly, DT | 3 |
| Ray, SG | 1 |
| McCann, G | 1 |
| Henderson, E | 2 |
| MacFarlane, N | 1 |
| Christie, J | 1 |
| Norrie, J | 1 |
| Grant, S | 2 |
| Verdecchia, P | 1 |
| Ruf, G | 1 |
| Trenk, D | 1 |
| Jähnchen, E | 1 |
| Roskamm, H | 1 |
| Hetzel, M | 2 |
| Wieshammer, S | 2 |
| Barnikel, U | 2 |
| Hetzel, J | 1 |
| Herb, S | 1 |
| Kochs, M | 2 |
| Hombach, V | 2 |
| Geller, NL | 2 |
| Knatterud, GL | 2 |
| Davies, RF | 2 |
| Day, P | 1 |
| Deanfield, JE | 1 |
| Goldberg, AD | 1 |
| McMahon, RP | 2 |
| Meyer, TE | 1 |
| Adnams, C | 1 |
| Commerford, P | 1 |
| Kurita, A | 1 |
| Takase, B | 1 |
| Uehata, A | 1 |
| Nishioka, T | 1 |
| Satomura, K | 1 |
| Nagayoshi, H | 1 |
| Mizuno, K | 1 |
| Woodmansey, PA | 1 |
| Stewart, AG | 1 |
| Morice, AH | 1 |
| Channer, KS | 1 |
| Foale, RA | 2 |
| Wallace, WA | 1 |
| Wellington, KL | 1 |
| Chess, MA | 1 |
| Liang, CS | 1 |
| Parameshwar, J | 1 |
| Keegan, J | 2 |
| Mulcahy, D | 4 |
| Phadke, K | 1 |
| Sparrow, J | 1 |
| Sutton, GC | 1 |
| Steffensen, R | 1 |
| Grande, P | 2 |
| Pedersen, F | 1 |
| Haunsø, S | 1 |
| Aschermann, M | 1 |
| Bultas, J | 1 |
| Danzig, V | 1 |
| Mayer, O | 1 |
| Lorenc, Z | 1 |
| Vortel, J | 1 |
| Kvasnicka, J | 1 |
| Raftery, EB | 5 |
| Lahiri, A | 5 |
| Hughes, LO | 3 |
| Rose, EL | 2 |
| Linden, W | 1 |
| Habibi, H | 1 |
| Klinke, WP | 1 |
| Nadeau, C | 1 |
| Phaneuf, DC | 1 |
| Lepage, S | 1 |
| Dessain, P | 1 |
| Buttars, JA | 1 |
| Pratt, CM | 1 |
| Goldstein, S | 1 |
| Andrews, TC | 1 |
| Dyrda, I | 1 |
| Hill, JA | 2 |
| Morgan, NA | 1 |
| Stone, PH | 1 |
| Sopko, G | 1 |
| Conti, CR | 2 |
| Findlay, I | 1 |
| Lezaun, R | 1 |
| Maraví, C | 1 |
| Gervás, H | 1 |
| Madariaga, I | 1 |
| Basterra, N | 1 |
| de los Arcos, E | 1 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
| Kaku, T | 1 |
| Himeno, E | 1 |
| Nakashima, Y | 1 |
| Kuroiwa, A | 1 |
| Burger, AJ | 1 |
| Kamalesh, M | 1 |
| Kumar, S | 1 |
| Nesto, R | 1 |
| Murakami, H | 1 |
| Nishimura, M | 1 |
| Urabe, K | 1 |
| Javeed, N | 1 |
| Javeed, H | 1 |
| Javeed, S | 1 |
| Moussa, G | 1 |
| Wong, P | 1 |
| Rezai, F | 1 |
| de Vries, RJ | 2 |
| van den Heuvel, AF | 1 |
| Lok, DJ | 1 |
| Claessens, RJ | 1 |
| Bernink, PJ | 2 |
| Pasteuning, WH | 1 |
| Kingma, JH | 1 |
| Dunselman, PH | 3 |
| Alpert, JS | 1 |
| van Kempen, LH | 1 |
| Bouwens, LH | 1 |
| Holwerda, KJ | 1 |
| Herweijer, AH | 1 |
| Knight, CJ | 1 |
| Humphrey, SJ | 1 |
| Glasser, S | 1 |
| Stone, P | 1 |
| Deedwania, PC | 2 |
| Johnson, M | 1 |
| Fakouhi, TD | 1 |
| Wang, JX | 1 |
| Maruyama, K | 1 |
| Murakami, M | 1 |
| Endo, T | 1 |
| Komatsu, H | 1 |
| Akahane, M | 1 |
| de Rosis, F | 1 |
| Grasso, F | 1 |
| Berry, DC | 1 |
| Luca, S | 1 |
| Romeo, S | 1 |
| Toal, CB | 1 |
| Motro, M | 1 |
| Baird, MG | 1 |
| Klinke, P | 1 |
| Sclarowski, S | 1 |
| Zilberman, A | 1 |
| Marmor, A | 1 |
| Kostuk, WJ | 1 |
| Lotan, C | 1 |
| Weiss, A | 1 |
| Erne, P | 1 |
| Palant, A | 1 |
| Stolero, D | 1 |
| Bélanger, L | 1 |
| Turpie, A | 1 |
| Mitrovic, V | 3 |
| Miskovic, A | 2 |
| Straub, M | 1 |
| Beckmann, K | 1 |
| Thormann, J | 3 |
| Pitschner, H | 3 |
| Hollenberg, NK | 1 |
| Williams, GH | 1 |
| Anderson, R | 1 |
| Oehm, E | 1 |
| Hamm, C | 2 |
| Pehrsson, SK | 2 |
| Ringqvist, I | 1 |
| Ekdahl, S | 1 |
| Karlson, BW | 1 |
| Ulvenstam, G | 1 |
| Persson, S | 1 |
| Kaliuzhin, VV | 1 |
| Maleeva, MA | 1 |
| Pushnikova, EIu | 1 |
| Solovtsov, MA | 1 |
| Strau, M | 1 |
| Martsevich, SIu | 1 |
| Koniakhina, IP | 1 |
| Alimova, EV | 1 |
| Kutishenko, NP | 1 |
| Lerman, OV | 1 |
| Idrisova, EM | 1 |
| Borovkova, NV | 1 |
| Stepacheva, TA | 1 |
| Chernov, VI | 1 |
| Karpov, RS | 1 |
| Dorow, P | 2 |
| Thalhofer, S | 1 |
| Bethge, H | 2 |
| Disselhoff, G | 1 |
| Wagner, G | 1 |
| Maniscalco, MM | 1 |
| Newton, W | 1 |
| Hassager, C | 1 |
| Thygesen, K | 1 |
| Fischer Hansen, J | 1 |
| Mickley, H | 1 |
| Gustafsson, I | 1 |
| Skagen, K | 1 |
| Steensgaard-Hansen, F | 1 |
| Patrizi, R | 1 |
| Leonardo, F | 1 |
| Pelliccia, F | 1 |
| Chierchia, SL | 1 |
| Galetta, P | 1 |
| Cerquetani, E | 1 |
| Frascà, F | 1 |
| Fini, M | 1 |
| Rosano, GM | 1 |
| Erikssen, J | 1 |
| Osvik, K | 1 |
| Dedichen, J | 1 |
| Heel, RC | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Robinson, C | 2 |
| Kitson, D | 1 |
| Jewitt, DE | 1 |
| Mäkynen, P | 1 |
| Karhumäki, L | 1 |
| Seppänen, S | 1 |
| Sowton, E | 1 |
| Perks, WH | 1 |
| Chatterjee, SS | 1 |
| Fisk, C | 1 |
| Jewitt, D | 1 |
| Gausi Gene, C | 1 |
| Richart Martínez, JA | 1 |
| De Rabago González, P | 1 |
| Bros Caimari, R | 1 |
| García Gallego, F | 1 |
| de Feijter, PJ | 1 |
| Roos, JP | 1 |
| Bachmann, M | 1 |
| Raeber, E | 1 |
| Burckhardt, D | 1 |
| Schwytzer, F | 1 |
| Münch, U | 1 |
| Kappenberger, L | 1 |
| Nager, F | 1 |
| Simonsen, S | 1 |
| Aström, H | 1 |
| Vallin, H | 1 |
| Saul, PA | 1 |
| Oliver, IM | 1 |
| Russell, WA | 1 |
| Boberg, J | 2 |
| Larsen, FF | 1 |
| de Muinck, ED | 1 |
| Buchner-Moell, D | 1 |
| van de Ven, LL | 1 |
| Lie, KI | 1 |
| McLenachan, JM | 4 |
| Wilson, JT | 4 |
| el-Tamimi, H | 3 |
| Davies, GJ | 3 |
| Bassan, MM | 1 |
| Rogel, S | 1 |
| Antalóczy, Z | 2 |
| Kékes, E | 2 |
| Ferraro, S | 2 |
| D'Agosto, V | 2 |
| D'Alto, M | 1 |
| Fazio, S | 2 |
| Santomauro, M | 2 |
| Romano, M | 3 |
| Chiariello, M | 3 |
| Bristol, DR | 1 |
| Gaspardone, A | 1 |
| Crea, F | 2 |
| Kaski, JC | 3 |
| Maseri, A | 3 |
| McLenachan, J | 2 |
| Akhras, F | 3 |
| Höher, M | 1 |
| Seibold, H | 1 |
| Waysbort, J | 1 |
| Meshulam, N | 1 |
| Brunner, D | 1 |
| Hopkinson, ND | 1 |
| Hui, KP | 1 |
| Smith, MP | 1 |
| Hollinrake, K | 1 |
| France, LA | 1 |
| Lewis, JA | 1 |
| Kay, R | 1 |
| Gilligan, DM | 1 |
| Chan, WL | 1 |
| Stewart, R | 1 |
| Oakley, CM | 1 |
| Floris, B | 1 |
| Paoletti, G | 1 |
| Pelizza, L | 1 |
| Bertulla, A | 1 |
| Motolese, M | 1 |
| Ogasawara, S | 1 |
| Ram, J | 1 |
| Fitscha, P | 1 |
| Meisner, W | 1 |
| Tiso, B | 1 |
| Carbajal, EV | 1 |
| Nelson, JR | 1 |
| Hait, H | 1 |
| Gonzalez, JI | 1 |
| Kolb, R | 1 |
| Challenor, VF | 2 |
| Cohn, PF | 1 |
| Bowles, MJ | 1 |
| Smith, L | 1 |
| Glover, DR | 1 |
| Pupita, G | 1 |
| Galassi, AR | 2 |
| Pedersen, TR | 1 |
| Kantor, M | 1 |
| Todd, IC | 2 |
| Ballantyne, D | 2 |
| Jackson, NC | 1 |
| Lee, PS | 1 |
| Taylor, SH | 1 |
| Kohli, RS | 2 |
| Harron, DW | 1 |
| Deering, AH | 1 |
| Scott, M | 1 |
| McMahon, M | 1 |
| Shanks, RG | 1 |
| Renwick, AG | 1 |
| George, CF | 1 |
| Hertzeanu, H | 1 |
| Shemesh, J | 1 |
| Loidl, AF | 1 |
| Kellermann, JJ | 1 |
| Chambers, J | 1 |
| Ong, ML | 1 |
| Adam, G | 1 |
| Noguchi, K | 1 |
| Ojiri, Y | 1 |
| Nagamine, F | 1 |
| Matsuzaki, T | 1 |
| Sakanashi, M | 1 |
| Rafflenbeul, W | 1 |
| Jost, S | 1 |
| Berger, C | 1 |
| Lichtlen, P | 1 |
| Douard, H | 2 |
| Mora, B | 2 |
| Shapiro, W | 1 |
| Narahara, KA | 1 |
| Thandroyen, F | 1 |
| Zohman, LR | 1 |
| Merino, A | 1 |
| Alegría, E | 1 |
| Castelló, R | 1 |
| Fidalgo, M | 1 |
| Abecia, A | 1 |
| Martínez-Caro, D | 1 |
| Piovaccari, G | 1 |
| Melandri, G | 1 |
| Marzocchi, A | 1 |
| Scarfoglio, D | 1 |
| Sanguinetti, M | 1 |
| Magnani, B | 1 |
| Pinelli, G | 1 |
| Di Pasquale, G | 1 |
| Slagle, DA | 1 |
| Vejar, M | 1 |
| Solomon, SA | 1 |
| Khurmi, NS | 1 |
| Kardash, MM | 1 |
| Salonen, JT | 1 |
| Taskinen, E | 1 |
| Salonen, R | 1 |
| Seppänen, K | 1 |
| Venäläinen, J | 1 |
| Rauramaa, R | 1 |
| Tönnesmann, U | 1 |
| Jamal, SM | 1 |
| Harris, PJ | 1 |
| Rodrigues, EA | 1 |
| Lawrence, JD | 1 |
| Dasgupta, P | 1 |
| Hains, AD | 1 |
| Wilkinson, PR | 1 |
| Tarnow, J | 1 |
| Komar, K | 1 |
| Cunningham, D | 1 |
| Quyyumi, A | 1 |
| Crean, P | 1 |
| Park, A | 1 |
| Soberman, JE | 1 |
| Wilson, J | 1 |
| Dargie, H | 2 |
| Lamon, KD | 1 |
| Pesciatini, F | 1 |
| Lazzaroni, A | 1 |
| Cerri, B | 1 |
| Maltz, MB | 1 |
| Dymond, DS | 1 |
| Nathan, AW | 1 |
| Camm, AJ | 1 |
| Lai, C | 1 |
| Onnis, E | 1 |
| Pirisi, R | 1 |
| Orani, E | 1 |
| Delogu, G | 1 |
| Cherchi, A | 1 |
| MacLeod, K | 2 |
| Ford, M | 1 |
| Gillen, G | 2 |
| Elliott, AT | 2 |
| James, MA | 1 |
| Papouchado, M | 1 |
| Jordan, SC | 1 |
| Sandberg, M | 1 |
| Di Maro, T | 1 |
| Carella, G | 1 |
| Cotecchia, MR | 1 |
| Caiazzo, MR | 1 |
| de Arcangelis, E | 1 |
| Condorelli, M | 1 |
| Lamb, RK | 1 |
| Prabhakar, G | 1 |
| Thorpe, JA | 1 |
| Smith, S | 1 |
| Norton, R | 1 |
| Dyde, JA | 1 |
| Chierchia, S | 1 |
| Glazier, JJ | 1 |
| Gerosa, S | 1 |
| Sermon, F | 1 |
| Crake, T | 2 |
| Wright, CM | 1 |
| Mockus, LJ | 1 |
| Bass, C | 1 |
| Upward, J | 1 |
| Keates, J | 1 |
| Lowe, D | 1 |
| Harry, J | 1 |
| McGuinness, JB | 1 |
| Boström, PA | 1 |
| Balldin, M | 1 |
| Lilja, B | 1 |
| Johansson, B | 1 |
| Aitchison, T | 1 |
| Carboni, GP | 1 |
| D'Ermo, M | 1 |
| Lewis, MJ | 1 |
| Henderson, AH | 1 |
| De Backer, GG | 1 |
| Derese, A | 1 |
| Wheatley, D | 1 |
| Fananapazir, L | 1 |
| Bray, C | 1 |
| Blasini, R | 1 |
| Brügmann, U | 1 |
| Reiniger, G | 1 |
| Rudolph, W | 1 |
| Jee, LD | 1 |
| Ashford, A | 1 |
| Walker, PR | 1 |
| Marshall, AJ | 1 |
| Farr, S | 1 |
| Bauminger, B | 1 |
| Walters, G | 1 |
| Barritt, DW | 1 |
| McLean, AJ | 1 |
| Knight, R | 1 |
| Harrison, PM | 1 |
| Harper, RW | 1 |
| Ceci, V | 1 |
| Longo, A | 1 |
| Di Mario, F | 1 |
| Fiorella, AT | 1 |
| Aiello, P | 1 |
| Masini, V | 1 |
| Hernández-Cañero, A | 1 |
| González, A | 1 |
| Cardonne, A | 1 |
| Pérez-Medina, T | 1 |
| Garcia-Barreto, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| INternational VErapamil SR Trandolapril STudy[NCT00133692] | Phase 4 | 22,000 participants | Interventional | 1997-09-30 | Completed | ||
| Evaluation of the Anti-anginal Efficacy and Safety of Oral Administration of Ivabradine Compared to Placebo on Top of Background Therapy With Atenolol in Patients With Stable Angina Pectoris. A Four-month Randomised Double-blind, Parallel Group Internatio[NCT00202566] | Phase 3 | 750 participants (Anticipated) | Interventional | 2005-06-30 | Completed | ||
| Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock (ES-FISH)[NCT03437369] | Phase 4 | 22 participants (Anticipated) | Interventional | 2018-05-31 | Not yet recruiting | ||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy[NCT00338260] | Phase 3 | 496 participants (Actual) | Interventional | 1995-06-30 | Completed | ||
| [NCT00000478] | Phase 3 | 0 participants | Interventional | 1990-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for atenolol and Angor Pectoris
| Article | Year |
|---|---|
[What are the alternatives to betablockers in 2009?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failur | 2008 |
[Right ventricular involvement in hypertrophic cardiomyopathy. A case report and brief review of the literature].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Echocar | 2004 |
Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers.
Topics: Adrenergic beta-Antagonists; Anaphylaxis; Angina Pectoris; Atenolol; Emergency Treatment; Glucagon; | 2005 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressur | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Delayed-Action Pre | 1993 |
[Silent myocardial ischemia. Arguments in favor of treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Calcium Channel Blockers; | 1996 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
Refractory anaphylactoid shock potentiated by beta-blockers.
Topics: Adrenergic beta-Antagonists; Anaphylaxis; Angina Pectoris; Atenolol; Cardiac Catheterization; Combin | 1996 |
[Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report].
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chronic Disease; | 1999 |
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Atenolol; Central Nervous System; Hemodynamic | 1979 |
The combination of slow-release nifedipine and atenolol for stable angina.
Topics: Angina Pectoris; Atenolol; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Nifedipin | 1990 |
Celiprolol in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as Topic; Double | 1988 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorth | 1988 |
Smoking, catecholamines, and the ischemic myocardium.
Topics: Angina Pectoris; Atenolol; Catecholamines; Coronary Disease; Female; Heart; Humans; Male; Nifedipine | 1988 |
151 trials available for atenolol and Angor Pectoris
| Article | Year |
|---|---|
[Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combinatio | 2008 |
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Atenol | 2008 |
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; C | 2009 |
[Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
Topics: Adrenergic beta-1 Receptor Antagonists; Angina Pectoris; Atenolol; Bisoprolol; Comparative Effective | 2010 |
[Atenolol induced bradycardia in patients with stable angina: effects on exercise tolerance, myocardial perfusion and left ventricular contractility].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Coronary Circulation; Exercise Tolerance; Fe | 2002 |
A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Calcium Channel | 1993 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Chan | 2004 |
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Ateno | 2005 |
[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Combined Modality Therapy; Diet, Vege | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Antihypertensive Agents; Atenolol; Blood Pressure; Female; | 2008 |
[Coraxan and atenolol: similarities and differences in correction of clinical and functional indices in therapy of patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Coronary Disease; Female; Humans; Male; Midd | 2008 |
Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ambulatory Care; Angina Pectoris; Atenolol; Electrocardiog | 1981 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Electrocardiography; Half-Life; Heart Rate; | 1984 |
Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; | 1984 |
Atenolol: once-daily cardioselective beta blockade for angina pectoris.
Topics: Adult; Aged; Ambulatory Care; Angina Pectoris; Atenolol; Electrocardiography; Female; Hemodynamics; | 1980 |
A comparison of once and twice daily atenolol for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1983 |
Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.
Topics: Administration, Oral; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Drug Inte | 1983 |
Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine.
Topics: Angina Pectoris; Atenolol; Clinical Trials as Topic; Exercise Test; Female; Humans; Male; Middle Age | 1984 |
The effects of nifedipine, atenolol and that combination on left ventricular function.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Humans; Male; Middle Age | 1983 |
Combined therapy with Ca-antagonists and beta-adrenergic receptor blocking agents in chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Drug Therapy, Combination; | 1984 |
[Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Age | 1984 |
[Effect of chronic administration of atenolol on exercise tolerance in angina].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1981 |
Improved exercise performance following single daily dose of atenolol in stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Electrocar | 1983 |
[Atenolol (Tenormin) in the treatment of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Human | 1980 |
Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Dru | 1980 |
[Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Metho | 1981 |
[Evaluation by exercise test of effects of a single oral dose of atenolol in patients with stable angina (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Coronary Circulati | 1981 |
Relative activities of atenolol and metoprolol on the cardiovascular system of man.
Topics: Adolescent; Adult; Angina Pectoris; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Hear | 1981 |
In vivo regulation of human cardiac beta-adrenoceptors by a partial agonist as compared with a full antagonist: selective differences in coupling to adenylate cyclase.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Angina Pectoris; Atenolol; Double-Blind Method; Down-Re | 1993 |
A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Cross-Ove | 1995 |
Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel B | 1995 |
Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol.
Topics: Aged; Angina Pectoris; Atenolol; Celiprolol; Cross-Over Studies; Double-Blind Method; Electrocardiog | 1994 |
Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzopyrans; Blood Pressure; Co | 1994 |
Effects of antianginal therapy with atenolol and slow-release nifedipine on respiratory gas exchange and on the ventilatory requirements for aerobic exercise.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Carbon Dioxide; Delayed-Action Preparations; Electrocardiogr | 1994 |
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Topics: Aged; Angina Pectoris; Atenolol; Diltiazem; Drug Therapy, Combination; Female; Humans; Isosorbide Di | 1994 |
Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Double-Blin | 1993 |
Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial.
Topics: Aged; Amlodipine; Angina Pectoris; Atenolol; Blood Pressure; Cardiac Output; Double-Blind Method; Ex | 1993 |
Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Coronary Disease; Delayed-Action Preparation | 1993 |
Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
Topics: Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Delayed-Action Preparations; Double-Bl | 1994 |
Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double blind randomised trial.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Therapy, Combination; Exercise; Fe | 1993 |
Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia.
Topics: Adult; Angina Pectoris; Atenolol; Chronic Disease; Delayed-Action Preparations; Diltiazem; Double-Bl | 1993 |
[Comparison of the effects and safety of atenolol and nifedipine in the treatment of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Exercise Test; Female; Humans; Male; Middle Aged; Nifedipine | 1993 |
A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Coronary Circulation; Coronary Disease; Double-Blin | 1993 |
Relative importance of psychologic traits and severity of ischemia in causing angina during treadmill exercise. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
Topics: Amlodipine; Angina Pectoris; Atenolol; Exercise Test; Exercise Tolerance; Female; Humans; Male; Midd | 1993 |
A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Delayed-Action Preparations; Dose-Response Relationship, Dru | 1993 |
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
Topics: Angina Pectoris; Atenolol; Case-Control Studies; Delayed-Action Preparations; Diltiazem; Drug Therap | 1996 |
Pointers from recent multicentre trials using ambulatory monitoring--placing placebo in perspective.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Coronary Disease; Drug Therapy, | 1995 |
Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Calcium Channel Blockers; Coron | 1996 |
The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Calcium Channel Blockers; Delay | 1996 |
Effect of sustained release diltiazem (Diltiazem-R) in patients with stable effort angina.
Topics: Angina Pectoris; Antihypertensive Agents; Atenolol; Cross-Over Studies; Delayed-Action Preparations; | 1994 |
Effect of beta adrenergic receptor blockade on cardiac autonomic tone in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Autonomic Nervous System; Betaxolol; Electro | 1996 |
Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Met | 1996 |
Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzimidazoles; Calcium Channel Blockers; Ch | 1998 |
Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Calcium Channel | 1997 |
Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris | 1998 |
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; | 1998 |
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium | 1999 |
Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Chronic Disease; Double-Blind Method; | 1999 |
[Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Bridged Bicyclo Comp | 1999 |
Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris | 2000 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Age | 2000 |
Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; | 2000 |
Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Bridged Bicycl | 2000 |
[Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Animals; Atenolol; Carbazoles; Carvedilol; Doubl | 2001 |
[The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Dose-Response Relationship, Drug; Drug Resis | 2001 |
Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; | 1990 |
Different effects of calcium antagonist and beta-blocker therapy on left-ventricular diastolic function in ischemic heart disease. A direct comparison of the impact of mibefradil and atenolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Blood Flow Velocity; Blood Pressure; C | 2001 |
Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease | 2001 |
Atenolol in the treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as To | 1977 |
Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Dru | 1978 |
Atenolol once daily in angina.
Topics: Adult; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Fe | 1979 |
Effects of atenolol in angina.
Topics: Adult; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Huma | 1977 |
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
Topics: Adult; Airway Obstruction; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trials as Topic; Dou | 1978 |
Haemodynamic effects of atenolol in patients with coronary artery disease.
Topics: Adult; Angina Pectoris; Atenolol; Clinical Trials as Topic; Coronary Disease; Dose-Response Relation | 1978 |
[Clinical trial of the new beta-blockader atenolol].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Evaluati | 1977 |
Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Dru | 1979 |
[Atenolol in the treatment of angina pectoris].
Topics: Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle | 1979 |
Effect of atenolol on exercise haemodynamics in angina pectoris and hypertension (abstract).
Topics: Angina Pectoris; Atenolol; Hemodynamics; Humans; Hypertension; Physical Exertion; Propanolamines; Pr | 1977 |
Tolerance and long-term efficacy of a fixed combination of atenolol and nifedipine in the treatment of angina pectoris. Stuart Clinical Research Group.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Drug Combinations; Female; Humans; Long-Term Care; Male; Mid | 1992 |
The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Benzeneacetamides; Blood Pressure; Cor | 1992 |
Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Atenolol; Bisoprolol; Double-Blind Method; Electroc | 1992 |
Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Betaxolol; Blood | 1992 |
Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Double-Blind Method; Drug Administration S | 1992 |
A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration.
Topics: Administration, Cutaneous; Aged; Angina Pectoris; Atenolol; Blood Pressure; Dose-Response Relationsh | 1992 |
Anti-anginal effect of Tenormin (atenolol).
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Coronary Angiography; Electrocardiography; E | 1992 |
The analysis of failure time data in crossover studies.
Topics: Angina Pectoris; Atenolol; Nifedipine; Proportional Hazards Models; Research Design; Time Factors | 1992 |
The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Data Interpretation, Statistical; Double-B | 1992 |
Effects of beta 2-adrenoceptor stimulation on exercise-induced myocardial ischemia.
Topics: Adult; Aged; Albuterol; Angina Pectoris; Atenolol; Blood Pressure; Exercise Test; Female; Heart Rate | 1991 |
Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Cardiac Output; Celiprolol; Coronary Disease | 1991 |
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Drug Combinations; Exercise Te | 1991 |
Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Carbon Dioxide; Delayed-Action Preparations; | 1991 |
Isosorbide-5-mononitrate and atenolol in the treatment of stable exertional angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Exe | 1991 |
A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris.
Topics: Angina Pectoris; Atenolol; Delayed-Action Preparations; Double-Blind Method; Drug Administration Sch | 1991 |
Clinical investigation of asymptomatic cardiac ischemia.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Atenolol; Coronary Artery Bypass; Coronary Disease; | 1991 |
A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Delayed-Action Preparations; Double-Blind Me | 1991 |
Comparison of bopindolol and atenolol in chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Exercise Test; Fe | 1990 |
Beta-blocker duration of action and implications for therapy.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Circadian Rhythm; Double-Blind Method | 1990 |
Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.
Topics: Angina Pectoris; Atenolol; Circadian Rhythm; Coronary Disease; Double-Blind Method; Electrocardiogra | 1991 |
Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Double-Blind Method; Drug Therapy, Combina | 1991 |
Comparison of nicorandil and atenolol in stable angina pectoris.
Topics: Angina Pectoris; Atenolol; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; | 1990 |
Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Blood Pressure; | 1990 |
Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; | 1990 |
Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Capsules; Double-Blind Method; Drug Administration | 1990 |
Antianginal efficacy of exercise training: a comparison with beta blockade.
Topics: Angina Pectoris; Atenolol; Exercise Test; Exercise Therapy; Heart Rate; Humans; Male; Middle Aged; R | 1990 |
A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
Topics: Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as Topic; Exercise Test; Humans; Propanolamin | 1986 |
Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Do | 1986 |
Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Clonidine; Double-Blind Method; Drug Evaluation; D | 1989 |
Slow release nifedipine plus atenolol in chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Delayed-Action Preparations; Double-Blind M | 1989 |
Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Evaluation; | 1989 |
Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzeneacetamides; | 1989 |
Results of a long term multicentre study in Sweden.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzeneacetamides; Exercise Test; Humans; Mu | 1989 |
Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Exercise Test; Female; | 1989 |
[Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].
Topics: Angina Pectoris; Atenolol; Coronary Angiography; Coronary Circulation; Coronary Disease; Gallopamil; | 1989 |
Comparison of the anti-anginal efficacy of nicardipine and nifedipine in patients receiving atenolol: a randomized, double-blind, crossover study.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Syner | 1989 |
Comparison of atenolol and nifedipine in chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Chronic Disease; Double-Blind Method; Electrocardiography; Exercise | 1989 |
Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolo | 1985 |
Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; | 1986 |
Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Angina Pectoris; Atenolol; Bisoprolol; Double | 1986 |
Comparison of carvedilol and atenolol for angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Blood Pressure; Carbazoles; Carvedilol; Clin | 1987 |
Atenolol and celiprolol for stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as | 1988 |
Comparison of bevantolol and atenolol in chronic stable angina.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trial | 1988 |
Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Celiprolol; Cli | 1988 |
Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Circadian Rhythm; Clinical Trials as Topic; Coronary Disease | 1988 |
Celiprolol in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as Topic; Double | 1988 |
Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Cardiac Output; Celiprolol; Exercise; Exerci | 1988 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorth | 1988 |
Celiprolol and atenolol in angina--effects on left ventricular function.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as | 1988 |
Efficacy of atenolol in the short and long-term treatment of patients with effort stable angina.
Topics: Angina Pectoris; Atenolol; Double-Blind Method; Drug Administration Schedule; Electrocardiography; F | 1989 |
A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Clinical Trials as Topic; Drug Adminis | 1987 |
Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Administ | 1988 |
Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind | 1988 |
Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Humans; Male; Middle Aged; Nifedipine; Nitrogl | 1986 |
Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Thera | 1988 |
Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Double-Blind Method; Drug Therapy, Combina | 1988 |
The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery.
Topics: Angina Pectoris; Atenolol; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Female; Hu | 1988 |
Smoking, catecholamines, and the ischemic myocardium.
Topics: Angina Pectoris; Atenolol; Catecholamines; Coronary Disease; Female; Heart; Humans; Male; Nifedipine | 1988 |
A single-blind, placebo-controlled study of effects of atenolol on transient ischemia in "mixed" angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Electrocardiography; Exercise Test | 1987 |
[Comparative effect of atenolol and verapamil in exertion angina. A single-blind crossed study with computerized exercise test].
Topics: Angina Pectoris; Atenolol; Clinical Trials as Topic; Computers; Exercise Test; Humans; Male; Middle | 1987 |
Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Topics: Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; | 1987 |
Does atenolol improve physical and psychological function after coronary artery bypass surgery: a controlled study.
Topics: Angina Pectoris; Anxiety Disorders; Arousal; Atenolol; Clinical Trials as Topic; Combined Modality T | 1987 |
Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.
Topics: Angina Pectoris; Atenolol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Metho | 1987 |
The effect of atenolol on the left ventricular performance in patients with angina pectoris measured with isotope technique.
Topics: Adult; Angina Pectoris; Atenolol; Exercise Test; Female; Heart; Heart Ventricles; Humans; Male; Midd | 1988 |
A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-B | 1987 |
Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Metho | 1985 |
A comparison of diltiazem and atenolol in angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Clinical Trials as Topic; Dilt | 1985 |
Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Metho | 1985 |
[Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Topics: Angina Pectoris; Atenolol; Biotransformation; Coronary Disease; Delayed-Action Preparations; Drug Ad | 1985 |
Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris.
Topics: Adult; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Fema | 1985 |
Effect of atenolol in angina pectoris of effort.
Topics: Adult; Angina Pectoris; Atenolol; Double-Blind Method; Exercise Test; Female; Humans; Hypertension; | 1972 |
65 other studies available for atenolol and Angor Pectoris
| Article | Year |
|---|---|
Beating, Fast and Slow.
Topics: Angina Pectoris; Atenolol; Biopsy; Bradycardia; Chest Pain; Diabetes Mellitus, Type 2; Diagnosis, Di | 2017 |
[Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Coronary Disease; Drug Therapy | 2014 |
[Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Clinical Trials as Topic; Coro | 2014 |
A new combination therapy in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Drug Th | 2009 |
Provokable left ventricular outflow tract obstruction in a patient without hypertrophy.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Cardiac Pacing, Artificial; Diagnostic Imaging; D | 2009 |
Angina: Ivabradine for treatment of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Chroni | 2009 |
Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.
Topics: Aged; Albuminuria; Angina Pectoris; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol, | 2010 |
Stable angina: role of ivabradine unchanged between 2006 and 2010.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Hum | 2010 |
[Ischemic heart disease in patients with arteriopathies].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Antihypertensive Agents; Arterioscle | 2002 |
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens | 2003 |
[Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; | 2003 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Age | 2004 |
Ivabradine: new drug. Best avoided in stable angina.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Benzazepines; Calcium Channel Bl | 2007 |
Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Blood Pressure; Dru | 1982 |
Managing angina with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Humans; Metoprolol; Nadolol; Nitrates; Propa | 1982 |
[Evaluation of anti-angina therapy by means of the treadmill test].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Bupranolol; Drug Therapy, Combination; Exerc | 1982 |
[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Echocardiography; Exercise Test; Hemo | 1983 |
Beta blockers and verapamil: a cautionary tale.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Humans; Middle Aged; Verapamil | 1984 |
[Antianginal and hemodynamic effect of propranolol and atenolol in patients with exertion angina].
Topics: Adult; Angina Pectoris; Atenolol; Drug Evaluation; Echocardiography; Exercise Test; Hemodynamics; Hu | 1984 |
[Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Drug Synergism; Heart Function Tests; Heart | 1984 |
Propranolol-induced depression: mechanism and management.
Topics: Adult; Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Male; Middle Ag | 1983 |
[Effect of atenolol in the treatment of hypertension and angina pectoris].
Topics: Angina Pectoris; Atenolol; Female; Humans; Hypertension; Male; Middle Aged | 1983 |
[Use of Falicard and Sectral in patients with COPD and ischemic heart disease].
Topics: Angina Pectoris; Atenolol; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Lun | 1983 |
[The effects of atenolol on the exercise symptoms of coronary patients. A double blind study (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Dose-Response Relationship, Drug; Double-B | 1981 |
[Withdrawal syndrome following beta blocker therapy (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Middle Aged; Myocard | 1981 |
Comparison of the combination of nifedipine and atenolol with the combination of nitroglycerine and atenolol in patients with angina pectoris.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Exercise Test; Heart Rate; Humans; Male; Nifed | 1980 |
[Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. Evaluation with the bicycle ergometer].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Coronary Disease; Drug Evaluation; Drug Tolerance; Exercise | 1983 |
Substitution of atenolol for propranolol in a case of propranolol-related depression.
Topics: Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Imipramine; Middle Age | 1982 |
[Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris].
Topics: Adult; Angina Pectoris; Atenolol; Drug Therapy, Combination; Humans; Hypertension; Male; Middle Aged | 1982 |
[201-thallium stress scintigram in patients with coronary artery disease after administration of the cardioselective betablocker atenolol (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Coronary Circulation; Coronary Disease; Humans; Male; Middle Aged; | 1981 |
Haemodynamic and metabolic effects of atenolol in patients with angina pectoris.
Topics: Adult; Angina Pectoris; Atenolol; Coronary Circulation; Fatty Acids, Nonesterified; Hemodynamics; He | 1980 |
Adverse interaction between nifedipine and beta-blockade.
Topics: Angina Pectoris; Atenolol; Drug Interactions; Drug Therapy, Combination; Humans; Hypertension; Hypot | 1980 |
The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Adult; Aged; Angina Pectoris; Atenolol; Blood Pr | 1994 |
Relation between dynamic midventricular obstruction and unexplained chest pain in patients with normal echocardiograms at rest.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina P | 1996 |
[Stable angina pectoris: what is the role of calcium antagonists?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Clinical Trials as | 1997 |
Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs.
Topics: Angina Pectoris; Animals; Atenolol; Blood Pressure; Diltiazem; Dogs; Dose-Response Relationship, Dru | 1998 |
Antianginal effects of ranolazine in various experimental models of angina.
Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Anesthesia; Angina Pectoris; Animal | 1999 |
Refining instructional text generation after evaluation.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Artificial Intelligence; Aspirin; Atenolol; Decision M | 1999 |
[Depression of diurnal dispersion of sinus rhythm in patients after myocardial infarct].
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Circadian Rhythm; Da | 2000 |
Does a change to long-acting antianginals provide better symptom control, treatment satisfaction, and quality of life?
Topics: Activities of Daily Living; Adrenergic beta-Agonists; Aged; Angina Pectoris; Atenolol; Delayed-Actio | 2001 |
Effect of atenolol (ICI 66 082) on coronary haemodynamics in man.
Topics: Angina Pectoris; Atenolol; Cardiac Pacing, Artificial; Coronary Circulation; Female; Hemodynamics; H | 1977 |
Letter: Effect of new beta-adrenergic blocking agent.
Topics: Angina Pectoris; Atenolol; Humans; Practolol; Propanolamines; Statistics as Topic | 1975 |
Influence of atenolol on the relationship between heart rate and QT interval in patients with exercise-induced myocardial ischemia.
Topics: Administration, Oral; Angina Pectoris; Atenolol; Coronary Disease; Electrocardiography; Exercise Tes | 1992 |
Efficacy of nifedipine in combination treatments for angina.
Topics: Angina Pectoris; Atenolol; Drug Administration Schedule; Drug Therapy, Combination; Nifedipine | 1991 |
The analysis of failure time data in crossover studies.
Topics: Analysis of Variance; Angina Pectoris; Atenolol; Bias; Clinical Trials as Topic; Confidence Interval | 1991 |
Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Coronary Disease; Drug Hyperse | 1991 |
Effects of diltiazem and long-term beta 1-adrenergic blockade on hemodynamics and blood flow during exercise in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Cardiac Output; Diltiazem; Exercise; Hemodyn | 1990 |
[HR/QT ratio during ergometric test: influence of ischemia and beta blocking therapy].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Electrocardiography; Exercise Test; Female; | 1990 |
Silent myocardial ischemia--classification and management.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Humans; Hy | 1990 |
Alleviation of myocardial dysfunction and abnormal lactate metabolism during coronary stenosis in dogs by ICI 118,551.
Topics: Angina Pectoris; Animals; Atenolol; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disea | 1989 |
Complementary mechanisms of atenolol and diltiazem in the clinical improvement of patients with stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Cardiac Volume; Coronary Circulation; Diltia | 1989 |
[Multiple coronary fistulas to the left ventricle. An unusual cause of myocardial ischemia].
Topics: Angina Pectoris; Angiography; Atenolol; Coronary Angiography; Coronary Disease; Coronary Vessels; Fi | 1989 |
[Angina pectoris caused by dynamic coronary obstruction and beta-blockers].
Topics: Angina Pectoris; Atenolol; Humans; Nifedipine | 1989 |
The acute withdrawal of diltiazem and atenolol: a possible challenge to affective stability.
Topics: Adult; Angina Pectoris; Atenolol; Atrial Flutter; Bipolar Disorder; Diltiazem; Female; Humans; Hyper | 1989 |
Effects of diltiazem alone or with isosorbide dinitrate or with atenolol both acutely and chronically for stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Diltiazem; Drug Therapy, Combination; Exerci | 1989 |
Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Drug | 1985 |
Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bupranolol; Dobutamine; Hemodyn | 1988 |
Beta blocker treatment for angina with associated bradycardia.
Topics: Angina Pectoris; Atenolol; Bradycardia; Electrocardiography; Exercise Test; Heart Rate; Humans; Male | 1986 |
Abolition of exercise induced ST depression after exercise training and its recurrence after beta blockade.
Topics: Angina Pectoris; Atenolol; Exercise Test; Exercise Therapy; Heart Rate; Humans; Male; Middle Aged | 1988 |
[Atenolol-nifedipine combination in the therapy of exertion angina. An ergometric study].
Topics: Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Exercise Test; Female; Humans; Male; Mid | 1986 |
Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment.
Topics: Angina Pectoris; Atenolol; Humans; Substance Withdrawal Syndrome | 1986 |
Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment.
Topics: Angina Pectoris; Atenolol; Coronary Disease; Humans; Substance Withdrawal Syndrome | 1986 |
Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.
Topics: Adult; Angina Pectoris; Atenolol; Catecholamines; Female; Heart Rate; Humans; Male; Middle Aged; Nor | 1985 |
Clearance-based oral drug interaction between verapamil and metoprolol and comparison with atenolol.
Topics: Administration, Oral; Angina Pectoris; Atenolol; Drug Interactions; Drug Therapy, Combination; Femal | 1985 |
[Comparison between atenolol and verapamil in the treatment of unstable angina].
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Arrhythmias, Cardiac; Atenolol; Drug Evaluation; Hum | 1985 |